argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
588.67
-6.91 (-1.16%)
Nov 4, 2024, 4:00 PM EST - Market closed
argenx SE Employees
argenx SE had 1,148 employees as of December 31, 2023. The number of employees increased by 305 or 36.18% compared to the previous year.
Employees
1,148
Change (1Y)
305
Growth (1Y)
36.18%
Revenue / Employee
$1,662,595
Profits / Employee
-$35,098
Market Cap
35.34B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,148 | 305 | 36.18% |
Dec 31, 2022 | 843 | 193 | 29.69% |
Dec 31, 2021 | 650 | 314 | 93.45% |
Dec 31, 2020 | 336 | 148 | 78.72% |
Dec 31, 2019 | 188 | 83 | 79.05% |
Dec 31, 2018 | 105 | 32 | 43.84% |
Dec 31, 2017 | 73 | 15 | 25.86% |
Dec 31, 2016 | 58 | 17 | 41.46% |
Dec 31, 2015 | 41 | 9 | 28.13% |
Dec 31, 2014 | 32 | 10 | 45.45% |
Dec 31, 2013 | 22 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
IQVIA Holdings | 87,000 |
Humana | 67,600 |
Centene | 67,000 |
GE HealthCare Technologies | 51,000 |
Edwards Lifesciences | 19,800 |
Agilent Technologies | 18,100 |
IDEXX Laboratories | 11,000 |
ResMed | 9,980 |
ARGX News
- 4 days ago - Argenx: Strong CIDP Launch, But gMG Growth Propels Q3 Sales Beat - Seeking Alpha
- 4 days ago - argenx SE (ARGX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 days ago - argenx Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 11 days ago - argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024 - GlobeNewsWire
- 20 days ago - argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions - GlobeNewsWire
- 5 weeks ago - argenx: Myositis Data Could Add Billions In Value - Seeking Alpha
- 6 weeks ago - argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy - GlobeNewsWire
- 2 months ago - argenx to Present at Upcoming Investor Conferences - GlobeNewsWire